SPLITOAK STRATEGIES LLC

Lobbying for JOHNSON & JOHNSON SERVICES, INC. · Global biopharmaceutical, medical device and consumer product manufacturer.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 21, 2025

Bills named in this filing 2

Lobbying activity 1

Health Issues

H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.